Skip to main content
ACAD logo

ACADIA Pharmaceuticals Inc.

ACADNASDAQHealthcareBiotechnology

$19.12Today:- (-)1Y −5.65%

As of Oct 16, 2026 close

Market cap
$3.41B
P/E (TTM)
8.95
Forward P/E
5.20
Dividend yield
-
52-week range
$18.39$30.96
Volume (live)
-
Avg. volume (3M)
2.16M

ACADIA Pharmaceuticals Inc. (ACAD) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for ACADIA Pharmaceuticals Inc. stock.

Analyst Consensus Rating

Investment consensus from 18 professional research analysts

Consensus Rating

Buy
Based on 18 unique analysts
(24 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$33.36
+74.48% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ACAD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Tazeen Ahmad
BofA Securities
BuyReiterates
$31.00
Brian Abrahams
RBC Capital
BuyMaintains
$37.00 → $36.00
Brian Abrahams
RBC Capital
BuyMaintains
$37.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Ananda Ghosh
HC Wainwright
BuyMaintains
$37.00 → $33.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$31.00
Jason Butler
Citizens JMP
BuyMaintains
$36.00 → $33.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$36.00
Malcolm Hoffman
BMO Capital
BuyMaintains
$36.00 → $34.00
David Hoang
Deutsche Bank
BuyReiterates
$38.00 → $31.00
Yigal Nochomovitz
Citi
BuyMaintains
$40.00 → $33.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$31.00
Sean Laaman
Morgan Stanley
HoldInitiates Coverage
$27.00 → $28.00
Ashwani Verma
UBS
BuyInitiates Coverage
$45.00 → $49.00
Shaun Pruitt
Zacks Equity Research
BuyInitiates Coverage
-
Paul Matteis
Stifel Nicolaus
HoldMaintains
$25.00
Matthew Hershenhorn
Oppenheimer
HoldMaintains
$23.00 → $25.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$30.00 → $31.00
Ritu Baral
TD Cowen
BuyInitiates Coverage
$37.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Uy Ear
Mizuho
BuyReiterates
$35.00 → $36.00
Brian Abrahams
RBC Capital
BuyInitiates Coverage
$36.00 → $37.00
Kaibalya Pravo Dey
Zacks Equity Research
BuyInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ACAD?

The analyst consensus rating for ACAD is Buy, based on the latest ratings from 18 analysts over the last 90 days.

What is the average price target for ACAD?

The average 12-month price target for ACAD is $33.36, representing an upside of 74.5% from the Oct 16, 2026 close of $19.12.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.